Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

Alternating electric field therapy has been approved for glioblastoma (GBM). We have preclinical evidence for anticancer effects in GBM cell cultures and mouse xenografts with an oscillating magnetic field (OMF) generating device. Here we report OMF treatment of end-stage recurrent glioblastoma in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baskin, David S., Sharpe, Martyn A., Nguyen, Lisa, Helekar, Santosh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341943/
https://www.ncbi.nlm.nih.gov/pubmed/34367992
http://dx.doi.org/10.3389/fonc.2021.708017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341943/
https://www.ncbi.nlm.nih.gov/pubmed/34367992
http://dx.doi.org/10.3389/fonc.2021.708017

Ejemplares similares